Bio-ReCell and BIOTEM collaborate to enhance T-cell therapy
Bio-ReCell - 19-Feb-2025The partnership adds BIOTEM’s antibodies to Bio-ReCell’s kits to boost cell therapy precision and scale
Join the club for FREE to access the whole archive and other member benefits.
The partnership adds BIOTEM’s antibodies to Bio-ReCell’s kits to boost cell therapy precision and scale
Oxford Biomedica expects strong 2024 revenues after streamlining and focusing on gene therapy
Company is aiming to increase accessibility and affordability
Promises faster development and wider access of cell therapies for age-related diseases
This innovation may help pharmaceutical companies speed up and scale their production
Click on resource name for more details.
No blog posts found!